WO2022115755A1 - Systems and processes for detecting aerosolized viral loads - Google Patents

Abstract

Systems for detecting aerosolized viral loads in an airspace include a first and, optionally, a second volume of a liquid. The first volume includes particles sampled from the airspace, and the second volume is free of virus particles. A first conductivity probe is immersed in the first liquid, and a second conductivity probe is immersed in the second liquid. An alternating voltage is applied to each of the first and second conductivity probes. The difference between the resulting alternating currents through the first and second conductivity probes is determined, and is used to estimate the viral load in the first volume, and in the airspace.

Description

SYSTEMS AND PROCESSES FOR DETECTING AEROSOLIZED VIRAL LOADS

Cross-Reference to Related Applications

[0001] This application claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Application No. 63/119,454, filed 30 November 2020, the contents of which are incorporated by reference herein in their entirety.

[0002] This application is a continuation-in-part of, and claims priority under 35 U.S.C. §120 to U.S. Application No.: 17/461,907, filed 30 August 2021, the contents of which are incorporated by reference herein in their entirety.

[0003] This application claims priority under 35 U.S.C. §119(a) and (b) to Indian Patent Application No. 202121004520, filed 2 February 2021.

Background

[0004] COVID-19 and other viruses are spread through airborne transmission. It is known that maintaining good air circulation and low particulate levels within indoor spaces are some of the most effective ways to reduce the risk for humans to become infected by such viruses. Since the beginning of the COVID-19 pandemic, hundreds of products have been released in the market with the goal of achieving greater indoor air circulation and filtering, based on the assumption that these factors will lead to a virus-free airspace. Virus particles ejected from the human body by sneezing and exhaling, however, can have a relatively high velocity that makes it difficult to remove all of the particles from an indoor air space in an efficient and effective manner. Thus, no air circulation system or air filtration system can protect humans from airborne viruses and other pathogens with absolute efficacy and reliability. Also, chemical and ion-based air purification systems can present logistical and safety-related challenges, because these types of systems can be harmful to human health and thus can be used only when humans are not present.

Summary

[0005] The disclosed technology relates to systems and processes for detecting airborne viral loads. The technology addresses drawbacks of present air purification systems by accurately determining whether a space contains a detectable level of virus particles, thereby helping to identify the location and origin of an infection or potential infection. The systems and techniques also can be used to determine whether an air purification system is working effectively, by continually checking whether the airborne viral load in a space decreases following the sudden introduction of a virus into the space caused by, for example, the entrance of an infected person. Also, because airborne viruses can be spread via breathing and sneezing, an Internet of Things (IoT) based system such as that disclosed herein can be used readily to inform occupants throughout a building or other living space whether any part of the building or living space is sensing a higher viral load, and thus can act both as a locator of virus-spreading sources, and a warning system. Even if no air filtering or purification system is present in a particular space, which is common in public gatherings, the detection of viral loads by the disclosed system can be highly useful information because it can identify the need to disperse the gathering for safety-related reasons.

[0006] In one aspect of the disclosed technology, when a group of aerosolized virus particles are partially or fully dissolved or suspended in a solvent in the form of a liquid medium or a gel like solid/semi-solid medium, the particle count, i.e., the total number of virus particles, referred to hereinafter as the viral load, can be determined by estimating temporal features of the resulting conductivity signal from the medium around a specific frequency range and, optionally, by deploying a homodyne or heterodyne detection technique in which a reference medium free of virus particles is used to provide a reference frequency so that changes in the frequency of the conductivity signal from the medium are amplified and a larger signal to noise ratio thus can be achieved. If a reference medium and homodyne or heterodyne detection are not used, however, the viral load nevertheless can be determined based on the changes in the frequency of the conductivity signal from the medium, but with a reduced signal to noise ratio.

[0007] In another aspect of the disclosed technology, if a certain volume of air is passed over the medium over a period of time and the virus is separated from the air using particle separation techniques, such as electrostatic, gravimetric, or centrifugal separation techniques; and the virus is injected into the medium, the temporal/frequency domain change of conductivity of the medium can provide a good indication of viral load in the air. An electrochemical system employing this technique includes an air suction means; a virus separator; a virus injector; a specially engineered medium to receive effective charge transfer from RNA/DNA viruses; a differential conductivity meter that uses a difference in frequency to detect changes in viral loads; and a computing system, such as an edge computer, to estimate the viral load of the air from estimated temporal and, optionally, differential changes in the conductivity of the medium. Once the change is detected and a substantial viral load is confirmed or validated by an algorithm, the system can send an alarm signal and/or an activation signal via wireless or wireline transmission to an air disinfection system, a cleaning system, and/or concerned users. [0008] In another aspect of the disclosed technology, a system is provided for measuring the conductivity of a liquid medium or a gel-like solid or semi-solid medium in which airborne viruses have been forced to fall; and the resulting changes in the capacitive and resistive properties of the medium due to colloidal electrochemistry of the viral particles are monitored using a range of frequency detection techniques including, optionally, differential frequency detection techniques. Various control parameters can be implemented to facilitate the estimation of very low viral concentration levels in the medium. The control parameters can include, for example, the level of the medium, the temperature of the medium, statistical classification parameters, and the addition of a buffer to the medium to amplify the signal.

[0009] In another aspect of the disclosed technology, a method is provided for mechanically injecting a virus into a liquid or gel like solid/semi-solid medium that includes a dopant solution which neutralizes the virus faster and thus can facilitate the creation of a stronger and faster detection signal than would be possible otherwise.

[0010] In another aspect of the disclosed technology, a system for detecting the presence of a viral load in an airspace includes a conductivity probe; and a frequency generator communicatively coupled to the conductivity probe and configured to, during operation, apply an alternating voltage to the conductivity probe while the conductivity probe is immersed at least in part in a medium that includes a solvent, and particles sampled from the airspace and suspended in the solvent. The first alternating voltage causes an alternating current to flow between the conductivity probe and the frequency generator. The system further includes a computing device communicatively coupled to the frequency generator and configured to, during operation, determine a viral load in the medium based on a frequency response of the conductivity probe to the alternating voltage applied thereto.

[0011] In another aspect of the disclosed technology, system is further configured to, during operation, determine the viral load in the medium based on a correlation between the frequency response of the conductivity probe to the alternating voltage applied thereto, and the viral load. [0012] In another aspect of the disclosed technology, the system further incudes the medium, wherein the solvent is one of a liquid and a gel-like solid or semi-solid.

[0013] In another aspect of the disclosed technology, the solvent is selected from a class of materials capable of acting as a base of a colloidal suspension in which the particles are suspended after being separated from the airspace, and further capable of effecting a transfer of charge between particles and the solvent.

[0014] In another aspect of the disclosed technology, the solvent is one of deionized water; distilled water; isopropyl alcohol; ultra-low molal tris-salt medium; a mild basic salt medium; and di sodium laureth sulfosuccinate medium.

[0015] In another aspect of the disclosed technology, the solvent has conductivity of about one microsiemens or less.

[0016] In another aspect of the disclosed technology, the computing device is further configured to, during operation, extract one or more signal artifacts from a signal representing the frequency response of the conductivity probe to the alternating voltage applied thereto; and to correlate the viral load in the medium with the one or more signal artifacts to thereby reduce or eliminate false positives and false negatives in the viral load determined by the computing device.

[0017] In another aspect of the disclosed technology, the signal representing the frequency response of the conductivity probe to the alternating voltage applied thereto is a temporal signal. [0018] In another aspect of the disclosed technology, the signal representing the frequency response of the conductivity probe to the alternating voltage applied thereto is a frequency -based signal representing the conductivity of the medium. [0019] In another aspect of the disclosed technology, the computing device is further configured to correlate the one or more signal artifacts with the viral load in the medium using a rule engine developed from a machine learning technique.

[0020] In another aspect of the disclosed technology, the computing device is further configured to reduce or eliminate false positives and false negatives in the viral load determined by the computing device using at least one of a particulate matter level, a carbon dioxide level, and the presence or absence of people in the airspace.

[0021] In another aspect of the disclosed technology, the conductivity probe is a first conductivity probe; the frequency generator is a first frequency generator; and the medium is a first medium. The system further includes a second conductivity probe; and a second frequency generator communicatively coupled to the second conductivity probe and configured to, during operation, apply a second alternating voltage to the second conductivity probe while the second conductivity probe is immersed at least in part in a second medium that includes the solvent.

The second alternating voltage causes a second alternating current to flow between the second conductivity probe and the second frequency generator. The system further incudes a differential frequency detector communicatively coupled to the first and second frequency generators and the computing device and configured to, during operation, determine a frequency differential between the frequencies of the first and second alternating currents. The computing device is further configured to, during operation, determine the viral load in the first medium based on the frequency differential.

[0022] In another aspect of the disclosed technology, the second medium is free of virus particles. [0023] In another aspect of the disclosed technology, the computing device is further configured to determine a pattern difference between signals representing the frequency responses of the first and second conductivity probes to the respective first and second alternating voltages applied thereto, wherein the patterns are artifacts of the signals.

[0024] In another aspect of the disclosed technology, the computing device is further configured to, during operation, determine the viral load in the first medium using one of a homodyne and a heterodyne detection technique.

[0025] In another aspect of the disclosed technology, the computing device is further configured to estimate the viral load in the airspace based on the viral load in the first medium. [0026] In another aspect of the disclosed technology, the computing device is further configured to generate and send a notification when the viral load in the airspace is determined to be greater than a predetermined value.

[0027] In another aspect of the disclosed technology, the system further includes a visual altering device communicatively coupled to the computing device. The computing device is further configured to generate an output when the viral load in the airspace is determined to be greater than a predetermined value; and the visual alerting device is configured to generate a visual alert in response to the output of the computing device.

[0028] In another aspect of the disclosed technology, the system further includes an audible altering device communicatively coupled to the computing device. The computing device is further configured to generate an output when the viral load in the airspace is determined to be greater than a predetermined value; and the audible alerting device is configured to generate an audible alert in response to the output of the computing device. [0029] In another aspect of the disclosed technology, the computing device is an edge-cloud server.

[0030] In another aspect of the disclosed technology, the system further includes a particle collector in fluid communication with the airspace and configured to, during operation, separate the particles from a sample of the airspace.

[0031] In another aspect of the disclosed technology, the particle collector includes a coarse filter configured to remove from the sample of the airspace particles having a size greater than a predetermined value.

[0032] In another aspect of the disclosed technology, the coarse filter is configured to remove from the sample of the airspace particles having an aerodynamic diameter greater than about ten microns.

[0033] In another aspect of the disclosed technology, the particle collector further includes a particle separator configured to remove from the sample of the airspace the particles sampled from the airspace.

[0034] In another aspect of the disclosed technology, the system further includes a fan in fluid communication with the particle collector and configured to, during operation, direct the sample from the airspace and to the particle collector.

[0035] In another aspect of the disclosed technology, the system further includes a tube, such as the type of tube used on breathalyzer machines, in fluid communication with an interior of a chamber holding the solvent. The tube is configured so that a person can breathe into the tube and thereby introduce the virus into the solvent via the tube, so that the system can provide an indication as to whether the person is infected with a virus such as COVID-19. [0036] In another aspect of the disclosed technology, a process for detecting the presence of a viral load in an airspace includes providing a solvent; obtaining an air sample from the airspace; [0037] and separating particles from the air sample so that the particles become suspended in the solvent to form a medium. The process also includes immersing at least a portion of a conductivity probe in the medium; applying an alternating voltage to the conductivity probe; and determining a viral load in the medium based on a frequency response of the conductivity probe to the alternating voltage applied thereto.

[0038] In another aspect of the disclosed technology, determining a viral load in the medium based on a frequency response of the conductivity probe to the alternating voltage applied thereto includes determining the viral load in the medium based on a correlation between the frequency response of the conductivity probe to the alternating voltage applied thereto, and the viral load. [0039] In another aspect of the disclosed technology, providing a solvent includes selecting the solvent from a class of materials capable of acting as a base of a colloidal suspension in which the particles are suspended after being separated from the airspace, and further capable of effecting a transfer of charge between the particles and the solvent.

[0040] In another aspect of the disclosed technology, the process further includes reducing or eliminating false positives and false negatives in the viral load determination by extracting one or more signal artifacts from a signal representing the frequency response of the conductivity probe to the alternating voltage applied thereto; and correlating the viral load in the medium with the one or more signal artifacts.

[0041] In another aspect of the disclosed technology, correlating the viral load in the medium with the one or more signal artifacts includes correlating the viral load in the medium with the one or more signal artifacts using a rule engine developed from a machine learning technique. [0042] In another aspect of the disclosed technology, the process further includes reducing or eliminating false positives and false negatives in the viral load determination using at least one of a particulate matter level, a carbon dioxide level, and the presence or absence of people in the airspace.

[0043] In another aspect of the disclosed technology, the conductivity probe is a first conductivity probe; the medium is a first medium; and the alternating voltage is a first alternating voltage. The process further includes providing a second conductivity probe; and applying a second alternating voltage to the second conductivity probe while the second conductivity probe is immersed at least in part in a second medium that includes the solvent. The process also includes determining a differential between the frequency response of the first conductivity probe to the alternating voltage applied thereto and a frequency response of the second conductivity probe to the alternating voltage applied thereto; and determining the viral load in the medium based on the frequency differential.

[0044] In another aspect of the disclosed technology, the second medium is free of virus particles.

[0045] In another aspect of the disclosed technology, determining the viral load in the medium based on the frequency differential includes determining the viral load in the first medium based on one of a homodyne and a heterodyne frequency detection technique.

[0046] In another aspect of the disclosed technology, determining a viral load in the medium based on the frequency differential includes determining the viral load in the medium based on a predetermined relationship between the viral load in the first volume and the frequency differential. [0047] In another aspect of the disclosed technology, the process further includes maintaining the first and second media at substantially the same temperature.

[0048] In another aspect of the disclosed technology, the process further includes estimating the viral load in the airspace based on the viral load in the medium.

[0049] In another aspect of the disclosed technology, the process further includes generating and sending a notification when the viral load in the airspace is determined to be greater than a predetermined value.

[0050] In another aspect of the disclosed technology, separating particles from the air sample so that the particles become suspended in the solvent to form a medium includes separating particles having an aerodynamic diameter of about ten microns or less from the air sample. [0051] In another aspect of the disclosed technology, determining a viral load in the first volume based on a frequency response of the conductivity probe to the alternating voltage applied thereto includes determining a viral load in the first volume based on the frequency response of the conductivity probe to the alternating voltage applied thereto using an edge-cloud server.

[0052] In another aspect of the disclosed technology, the process further includes measuring a temperature and a relative humidity of the airspace; and determining a particle concentration in the airspace. The process also includes calculating a minimum separation distance needed to reduce a potential for human-to-human transmission of airborne pathogens, based on an estimate of distance the particles will travel upon being exhaled as determined using the temperature and relative humidity of the airspace, and the particle concentration in the airspace.

[0053] In another aspect of the disclosed technology, a combination of virus-air separation system directing virus to a liquid chamber, a frequency-based conductivity signal is fed into a signal processing system which correlates viral load with artifacts of the signal (such as variance, crest factor, higher order moments) and false positive or false negative elimination by signal analysis and combination of other sensor signals.

[0054] In another aspect of the disclosed technology, a combination of virus-air separation system directing virus to two liquid chambers (one reference and one probe), a differential frequency -based conductivity measuring in which differential frequency response from both the liquid chamber is fed into a signal processing system and a signal processing system to correlate signal artifacts such as skewness, variance with viral load and elimination of false positive or false negative by signal analysis and combination of other sensor signals [0055] In another aspect of the disclosed technology, a class of liquids (such as deionized water, ultra-low molal Tris-salt solution or mild basic salt solutions) that can act as a base of a colloidal solution in which virus is absorbed and this class of liquid can act as quick and effective charge transfer of virus into the liquid media.

[0056] In another aspect of the disclosed technology, a system of signal processing unit in which a temporal signal is converted into a number of artifacts such as variance, co-efficient of variation, skewness and many others similar features which has been shown to be correlated with the viral load.

[0057] In another aspect of the disclosed technology, a single artifact of the conductivity signal such as variance or a combination of multiple artifacts like variance, skewness etc., used in a rule engine developed from various machine learning techniques such as neural network, SVM, etc., that have been shown or known to correlate with viral load.

[0058] In another aspect of the disclosed technology, the elimination of the false positive and false negative reading by combining the viral load data with signals from particulates monitoring (PM sensors 1, 2.5 and 10 micron), proximity detection and carbon dioxide and use the data by a rule engine obtained from various Machine Learning techniques such as SVM (support vector machine), Neural Network, etc.

Description of the Drawings

[0059] The following drawings are illustrative of particular embodiments of the present disclosure and do not limit the scope of the present disclosure. The drawings are not to scale and are intended for use in conjunction with the explanations provided herein. Embodiments of the present disclosure will hereinafter be described in conjunction with the appended drawings. [0060] FIG. 1 is a block diagram of a system for detecting aerosolized viral loads.

[0061] FIG. 1A is diagrammatic illustration of the system shown in FIG. 1.

[0062] FIG. IB is a diagrammatic illustration of a sample chamber, a reference chamber, and probes of the system shown in FIGS. 1 and 1 A.

[0063] FIG. 2 is a flow chart depicting operation of the system shown in FIGS. 1-lB.

[0064] FIG. 2A is another flow chart depicting operation of the system shown in FIGS. 1-lB. FIG. 3 A is a diagrammatic illustration of a coarse filter of a particle collector of the system shown in FIGS. 1-lB

[0065] FIG. 3B is a diagrammatic illustration of an alternative embodiment of the coarse filter shown in FIG. 3 A.

[0066] FIG. 4A is a diagrammatic illustration of an aerosol sampler the particle collector of the system shown in FIGS. 1-lB, 3A, and 3B.

[0067] FIG. 4B is a diagrammatic illustration of an alternative embodiment of the aerosol sampler shown in FIG. 4A. [0068] FIG. 4C is a diagrammatic illustration of another alternative embodiment of the aerosol sampler shown in FIG. 4A.

[0069] FIG. 4D is a diagrammatic illustration of another alternative embodiment of the aerosol sampler shown in FIG. 4A.

[0070] FIG. 4E is a diagrammatic illustration of another alternative embodiment of the aerosol sampler shown in FIG. 4A.

[0071] FIG. 5 is a diagrammatic illustration of various electrical components of the system shown in FIGS. 1-lB and 3A-4E, with a graphical representation of various frequency measurements made using the components.

[0072] FIG. 6A is a graph depicting the relationship between the frequency of an alternating current through a first conductivity probe of an embodiment of the system shown in FIGS. 1-lB and 3 A-5, as a function of the viral load in a medium in which the probe is immersed.

[0073] FIG. 6B is a graph depicting the difference between the alternating current frequency depicted in FIG. 6A, and the frequency of an alternating current through a second conductivity probe immersed in a medium that does not contain a viral load, as a function of the viral load in which the first probe is immersed.

[0074] FIG. 7 is a block diagram of a validation, or error-elimination, process that can be performed by the system shown in in FIGS. 1-lB and 3 A-5.

[0075] FIG. 8 depicts a validation, or error-elimination algorithm that can be used to perform an alternative validation process to the validation process depicting in FIG. 7.

[0076] FIG. 9 depicts various statistical parameters used by the validation algorithm depicted in FIG. 8. [0077] FIG. 10 is a tabular presentation of the results of a validation process performed using the algorithm shown in Fig. 8.

[0078] FIG. 11 is a diagrammatic illustration of various display and alert devices of the system shown in in FIGS. 1-lB and 3A-5.

[0079] FIG. 12 is a diagrammatic representation depicting the classification of aerosol particles based on their diameters.

[0080] FIG. 13 is a diagrammatic representation depicting an alternative embodiment of the system shown in FIGS. 1-lB and 3A-5.

Detailed Description

[0081] The inventive concepts are described with reference to the attached figures, wherein like reference numerals represent like parts and assemblies throughout the several views. The figures are not drawn to scale and are provided merely to illustrate the instant inventive concepts. The figures do not limit the scope of the present disclosure or the appended claims. Several aspects of the inventive concepts are described below with reference to example applications for illustration. It should be understood that numerous specific details, relationships, and methods are set forth to provide a full understanding of the inventive concepts. One having ordinary skill in the relevant art, however, will readily recognize that the inventive concepts can be practiced without one or more of the specific details or with other methods. In other instances, well- known structures or operation are not shown in detail to avoid obscuring the inventive concepts. [0082] FIGS. 1-lB, 3A-5, and 11 disclose a system 10 for detecting an airborne viral load, and various components thereof. The system 10 uses alternating current (AC) conductivity measurement to determine the viral load in a colloidal suspension, or “sample medium,” formed from airborne virus particles from the monitored space, and a solvent into which the particles have been introduced after being separated from the air. The system 10 also uses a reference medium containing the same solvent, in the same volume, as the solvent used in the sample medium. The reference medium, however, does not include any virus particles. The refence medium is maintained at substantially the same environmental conditions as the sample medium. [0083] An alternating voltage is applied across the electrodes of a first probe immersed in the sample medium, i.e., the colloidal suspension formed by the sampled virus particles and the solvent into which the virus particles have been dispersed. A substantially identical alternating voltage is applied across the electrodes of a second probe immersed in the reference medium.

The voltage potential across the electrodes of the first and second probes causes an alternating current to flow through each probe. The difference between the frequencies of the respective alternating currents is determined using a homodyne detection technique. In alternative embodiments, the difference between the frequencies of the respective alternating currents is determined using a heterodyne detection technique.

[0084] The differential frequency response of the first and second probes can be used to estimate the viral concentration, including very low viral concentrations, in the sample medium. More specifically, the presence of a viral load in the sample medium affects the electrochemical characteristics of the solvent used to form the sample medium, which in turn affects the electrical conductivity and dielectric properties of the solvent. The change in electrical conductivity and dielectric properties affect the frequency of the alternating current passing between the electrodes of the probe immersed the sample medium by a very small, but detectable, amount. The differential frequency response of the probes immersed in the sample and reference media thus can be correlated to the presence and magnitude of the viral load in the sample medium. [0085] Alternative embodiments of the system 10 can be configured without the reference medium and without the second probe, and without the use of the homodyne or heterodyne detection to determine the differential frequency response of the first and second probes.

[0086] Also disclosed are mechanical methods for introducing the virus particles into the solvent; and a dopant that, when added to the solvent, enhances the Zeta potential and Debye radius of the resulting colloidal suspension in which charged virus particles have been trapped, thereby enhancing the overall sensitivity of the detection of the viral load. With the disclosed combination of mechanical, electrical, signal processing, and algorithmic features, the system 10 has been shown to be sensitive enough to detect small viral loads in the range of 100-150 particle/100 mL of air, with a high degree of reliability and repeatability.

[0087] The system 10 can be characterized as including, without limitation, three core component groups: an aerosol classification and bio-sampling group; a viral detection group that detects the presence and magnitude of a viral load based on changes in electrical properties of the medium in which viral particles are suspended; and an edge computation and IoT platform group that facilitates the elimination of errors in the acquired data, and generation of notifications and warnings when an airborne virus is detected.

[0088] In aerosol sampling, air quality generally is determined by: (i) determining the density of airborne particles of different sizes; (ii) determining the “health” of breathing space, i.e., whether the breathing space is too densely populated, and (iii) determining the air properties to scientifically calculate the air transport characteristics.

[0089] FIGS. 2A-2C are flow charts depicting operation of the system 10. The initial portion of the virus detection process performed by the system 10 comprises collecting air from throughout the room or other space in which the air quality is to be monitored; and isolating particles that potentially are the most conducive to causing an infection and spreading the virus. [0090] Referring to FIG. 12, a person infected with a respiratory virus typically emits a variety of aerosols that can be classified in accordance with their aerodynamic diameter. The aerodynamic diameter of a particle is defined as the diameter of a sphere of density 1 g/cm³ which suspends or settles in still air at same velocity as the particle. An infected person, in general, can emit aerosolized particles having aerodynamic diameters in the range of about 1 micron to about 200 microns. The particles having an aerodynamic diameter greater than about 100 microns are much less likely to remain airborne than the smaller diameter particles, and settle to the nearby ground very quickly after being emitted. Such particles, therefore, are highly unlikely spread the virus.

[0091] Aerosolized particles having an aerodynamic diameter in the range of about ten microns to about 100 microns are characterized as inhalable fractions. Such particles typically become trapped in the nose and mouth, and therefore are unlikely to cause an infection by way of the respiratory system.

[0092] Aerosolized particles with an aerodynamic diameter in the range of about four microns to about ten microns are characterized as thoracic fractions. As shown in FIG. 12, these types of particles readily can reach the throat and upper respiratory duct, and therefore are likely to result in infection and spreading of the virus.

[0093] Aerosolized particles having an aerodynamic diameter less than about four microns are characterized as respirable fractions. As shown in Fig. 12, these types of particles generally are considered the most dangerous because such particles can reach the finest parts of the lungs. Respirable particles, therefore, are responsible to a large extent for the spread of illnesses caused by airborne viral pathogens.

[0094] Thoracic and respirable particles are believed to make up a major portion of the viral load in a typical space in which the COVID-19 virus is spread. And as noted above, these types of particles, if inhaled, are highly likely to cause an infection. Hence, the system 10 is configured to target thoracic and respirable particles when estimating the viral load, to help maximize the detection of such potentially infectious particles, and decrease false readings based on the detection of larger particles.

[0095] The system 10 comprises a fan 22, depicted schematically in FIG. 1. The fan 22 is configured to draw ambient air from the space or volume of air being monitored for a viral load (step 100 in FIG. 2A). In one possible embodiment, the fan 22 can be configured to generate a suction that draws air from every direction around the fan 22, and from a distance of up to 12 feet away from the fan 22, to help maximize the area of coverage and the operational efficiency of the system 10. The fan 22 is communicatively coupled to a controller 23 of the system 10, as shown in FIG. 1. The controller 23 is configured activate and deactivate the fan 22 at the start and end of each sampling period.

[0096] Each sampling period can have a duration of, for example, about ten to about 100 seconds. The controller 23 can be configured to obtain a sample at predetermined intervals, such as about every one minute to about every ten minutes. The system 10 can be configured so that the sampling period and sampling intervals can be varied by the user via inputs provided through a suitable input device communicatively coupled to the controller 23. The system 10 also can be configured so that the user can initiate a sampling period on demand, by entering a command though the input device. The input device can be, for example, a smart phone 54; a desktop computer 56; a server, such as edge-cloud server 46; etc., equipped with a suitable application. The smart phone 54, a desktop computer 56, edge-cloud server 46, and other input devices can be communicatively coupled to the controller 23 by way of a wireless gateway 52 or other suitable means. The smart phone 54, desktop computer 56, edge-cloud server 46, and wireless gateway 52 are shown in FIGS. 1, 1A, and 11.

[0097] The controller 23 can be any type of computing device capable of performing the logical operations described therein. As a non-limiting example, the controller 23 can be a microcontroller comprising, in relevant part, a microprocessor; a memory communicatively coupled to the microprocessor; and computer executable instructions stored in the memory. The computer executable instructions are configured so that, upon execution by the microprocessor, the computer executable instructions cause the microcontroller to perform the logical operations disclosed herein.

[0098] The system 10 further comprises a particle collector 24, depicted schematically in FIG.

1. The particle collector 24 is in fluid communication with the fan 22; and is located downstream from the fan 22 so that the particle collector 24 receives the ambient air entrained by the fan 22. The particle collector 24 is configured to collect aerosolized virus particles likely to result in an infection, and to separate and eliminate aerosolized particles of no interest, i.e., larger particles that are unlikely to result in infection.

[0099] Referring to FIGS. 3 A and 3B, the particle collector 24 comprises a coarse filter that filters out, or eliminates particles having an aerodynamic diameter greater than about ten microns (step 102 in FIG. 2A). As discussed above, virus particles characterized as inhalable fractions, i.e., particles with an aerodynamic diameter greater than about ten microns, are highly unlikely to produce an infection. Thus, these particles are eliminated in the initial, or coarse filtration portion of the aerosol sampling process. The coarse filter can use any suitable technique to eliminate the inhalable fractions. For example, the coarse filter can comprise a filter mesh 26, shown in FIG. 3 A, that captures particles larger than about ten microns. Alternatively, the coarse filter can comprise a cyclonic filter 27, shown in FIG. 3B, having a cut-off particle diameter of about ten microns.

[0100] Referring to FIGS. 4A-4E, the particle collector 24 further comprises an aerosol sampler. The sampled air is directed to the aerosol sampler following removal of the inhalable fractions in the coarse filter. The aerosol sampler is configured to separate the thoracic and respirable fractions from the air flow after the larger particles have been removed by the coarse air filter (step 102 in FIG. 2 A). The aerosol sampler can use any suitable technique to perform this function. For example, as shown diagrammatically in FIG. 4A, the aerosol sampler can comprise an impinger 70 configured to capture aerosolized particles having an aerodynamic diameter of less than about ten microns.

[0101] Alternatively, as shown diagrammatically in FIG. 4B, the aerosol sampler can comprise a cyclonic filter 72 configured to capture aerosolized particles having an aerodynamic diameter of less than about ten microns.

[0102] Alternatively, as shown diagrammatically in FIG. 4C, the aerosol sampler can comprise a condensation-based separator 74 configured to introduce steam into the sampled airflow. The resulting condensation of causes aerosolized particles having an aerodynamic diameter of less than about ten microns to drop out of the airflow.

[0103] Alternatively, as shown in diagrammatically FIG. 4D, the aerosol sampler can comprise an impactor 76 configured to capture aerosolized particles having an aerodynamic diameter of less than about ten microns. [0104] Alternatively, as shown diagrammatically in FIG. 4E, the aerosol sampler can comprise an electrostatic precipitator 78 configured to capture aerosolized particles having an aerodynamic diameter of less than about ten microns.

[0105] The aerosol sampler is configured so that the thoracic and respirable fractions, upon being separated from the air stream, drop into, and become suspended in a dispersion medium, or solvent, positioned beneath the aerosol sampler as shown in FIGS. 4A-4E (step 106 in FIG. 2A). The sampled air from which the thoracic and respirable fractions have been separated is released back in the ambient environment to complete the bio sampling process.

[0106] The solvent into which the separated thoracic and respirable fractions are dispersed can be a class of liquids or gel-like solid or semi-solid media such as, for example, deionized water; distilled water; ultra-low molal tris-salt solution, mild basic salt solutions, isopropyl alcohol, disodium laureth sulfosuccinate (DLS) solution, and other types of liquids that can act as a base of a colloidal suspension into which virus particles are absorbed and suspended; that become polarized upon the absorption of the virus particles; and that can effect a quick and effective charge transfer between the virus particles and the medium.

[0107] After the aerosols are sampled and the thoracic and respirable fractions are suspended in the solvent to form the colloidal suspension, i.e., the sample medium, the system 10 detects whether the suspended particles contain any viruses. Airborne virus particles that have been separated from the air and suspended in a solvent, i.e., a dispersion medium, can change the electrochemical properties of the solvent; and the airborne viral load can be predicted or estimated by measuring the change in the electrical properties of the solvent caused by the presence of the virus particles. This in turn can facilitate the determination an airborne viral load in the space from which the particles were obtained. [0108] The electrochemical properties of the solvent, and the colloidal suspension formed using the solvent, also can be dependent on handling, i.e., shaking, which can result in vibrations that produce more electrostatic charge separation of the virus particles. The electrochemical properties of the solvent and the colloidal suspension also can be dependent on environmental factors such as the temperature of the solvent or the suspension. Therefore, to eliminate ambiguous or erroneous results due to changes in temperature and other environmental factors, the system 10 uses a two-chamber analysis technique in which one liquid-filled chamber is used as a reference, and the other liquid-filled chamber contains the colloidal suspension of entrapped sampled particles, i.e., the sample medium. More specifically, as shown in FIG. 1, the system 10 further comprises a reference chamber 30 containing the solvent with no dispersed virus particles, referred to hereinafter as a “reference medium;” and a sample chamber 32 containing the colloidal suspension of the virus particles and the solvent, i.e., the sample medium. Alternative embodiment of the system 10 can have a single-chamber configuration, i.e., alternative embodiments can be configured without the reference chamber 30 and can forgo the use of a reference medium.

[0109] As noted above, the thoracic and respirable fractions, upon being separated from the air sample in the aerosol sampler, are absorbed into a solvent in the form of a liquid medium, or a gel-like solid or semi-solid medium. Upon completion of the predetermined sampling period, the resulting colloidal suspension, or sample medium, is transferred to the sample chamber 32. The reference chamber 30 contains the same solvent, in the same volume, as the sample chamber 32, but the solvent in the reference chamber 30 does not include any absorbed particles. The solvent in the sample chamber 30, i.e., the reference medium, otherwise is substantially identical to the sample medium. [0110] Also, the reference medium in the reference chamber 30 is maintained at substantially the same environmental conditions, including temperature, as the sample medium in the sample chamber 32. The relevant properties of the reference medium, therefore, can act as a baseline against which changes of the conductivity of the sample medium can be evaluated. As discussed below, this technique helps to maximize the signal to noise ratio in the signal that ultimately is used as an indication of the viral load in the sample medium.

[0111] The two-chamber system 10 further includes a two-probe/four-electrode system to measure the relevant characteristics of the reference medium and sample medium in the respective reference chamber 30 and sample chamber 32. More specifically, the system 10 comprises a first conductivity probe 36 and an identical second conductivity probe 38, shown in FIGS. 1, IB, and 5. The first conductivity probe 36 and the second conductivity probe 38 each include a positive electrode 39a and a negative electrode 39b. The electrodes 39a, 39b of the first conductivity probe 36 are immersed in the sample medium in the sample chamber 32. The electrodes 39a, 39b of the second conductivity probe 38 are immersed in the reference medium in the reference chamber 30. Single-chamber versions of the system 10, i.e., alternative embodiments of the system 10 that do not incorporate the reference chamber 30, can be configured without the second conductivity probe 38.

[0112] As discussed below, the first and second conductivity probes 36, 38 form part of a homodyne frequency detection circuit. The frequency responses of the first and second conductivity probes 36, 38 are proportional to the respective electrical conductivities of the sample medium and the refence medium. As discussed below, the system 10 is configured to determine the differential frequency response between the first and second conductivity probes 36, 38, and to estimate the viral load in the sample medium based on the differential frequency response.

[0113] The system 10 also comprises a first alternating frequency generator 40, a second frequency generator 41, and a differential frequency detector 42, also shown in FIGS. 1 and 5. The first frequency generator 40 is communicatively coupled to the first probe 36, and to the differential frequency detector 42. The second frequency generator 41 is communicatively coupled to the second probe 38, and to the differential frequency detector 42. The first and second frequency generators 40, 41 each generate a sinusoidally-varying voltage that produces an alternating electrical potential across the positive and negative electrodes 39a, 39b of the respective first and second conductivity probe 36, 38 (activities 108a, 108b in FIG. 2A). The frequency of the voltage is characteristic of the RC (resistance/capacitance) of the alternating current (AC) circuit driving the alternating voltages. Single-chamber versions of the system 10 can be configured without the second frequency generator 41 and the differential frequency detector 42.

[0114] The electrical potential across the positive and negative electrodes 39a, 39b causes an alternating current to flow between the positive and negative electrodes 39a, 39b via the sample medium or the reference medium in which the respective first and second electrodes 39a, 39b are immersed. The frequencies of the alternating currents are related to the respective electrical conductivities of the sample and reference media. The sample medium, i.e., the colloidal suspension in the sample chamber 32, is polarized due to the presence of virus particles, such COVID-19 virus particles, that have spike proteins, since the presence of the spike proteins results in an electrostatic charge. Thus, the electrical conductivity of the sample medium is related to the presence, or absence, of virus particles in the sample medium. [0115] The first and second frequency generators 40, 41 each produce a sinusoidal output signal having a frequency approximately equal to the frequency of the alternating current flowing through the respective first and second probes 36, 38. The output signals are transmitted to the differential frequency detector 42. The differential frequency detector 42 determines the frequency difference between the signals using a homodyne detection technique (step 110 in FIG. 2A). The differential frequency detector 42 can determine the frequency differential, using a heterodyne detection technique, in alternative embodiments. The differential frequency detector 42 generates an output representative of the frequency differential, and sends the output to the controller 23. The differential frequency detector 42, the first and second frequency generators 40, 41, and the first and second probes 36, 38 thus constitute a homodyne frequency detection circuit. As discussed below, the frequency differential is processed to estimate the amount of virus particles in the sample medium within the sample chamber 32.

[0116] As noted above, the frequency of the alternating current flowing between the first and second probes 36, 38 and the respective first and second alternating frequency generators 40, 41 is related to the electrical conductivities of the respective sample and reference media in which the first and second probe 36, 38 are immersed; and the conductivity of the sample medium is related to the presence, or absence, of virus particles in the sample medium. Therefore, the frequency of the output signal generated by the first alternating frequency generator 40, i.e., the frequency response of the first probe 36 to the alternating voltage applied thereto, is related to the amount of virus particles in the sample medium.

[0117] The reference medium in the reference chamber 30 is substantially free of virus particles, and is maintained at substantially the same environmental conditions as the sample medium in the sample chamber 32. Therefore, the frequency of the output signal generated by the second frequency generator 41, i.e., the frequency response of the second probe 38 to the alternating voltage applied thereto, represents a baseline reference against which the effects of the any virus particles in the sample medium can be evaluated. By generating a signal representing the frequency difference between the respective frequency responses of the first and second probes 36, 38, and using the difference to determine the presence or absence of virus particles in the sample chamber 32, small changes in the frequency of the current through the first probe 36, in effect, are amplified, as can be seen in FIG. 5. This amplification, in turn, improves the signal to noise ratio in the output signal generated by the differential frequency detector 42, i.e., in the signal that ultimately is used to determine the presence and magnitude of the viral load in the sample medium.

[0118] The frequency response of the homodyne frequency detection circuit formed by the differential frequency detector 42, the first and second frequency generators 40, 41, and the first and second probes 36, 38 is proportional to the respective electrical conductivities of the sample and reference media. Also, the virus particles become electrically polarized upon being suspended in the solvent, causing the characteristic frequency of the sample medium to change monotonically with the viral load, i.e., the number of virus particles, in the sample medium.

Thus, by determining the temporal and (optionally) the differential changes in the conductivity of the solvent in the sample medium resulting from the introduction of the virus particles thereto, the frequency response of the homodyne circuit can be correlated with the amount of virus particles in the sample medium. The amount of virus particles in the sample medium, in turn, can provide an indication of the viral load in the airspace from which the virus particles were sampled. [0119] The output signal generated by the differential frequency detector 42, which represents the output of the homodyne frequency detection circuit, is transmitted to the controller 23, which in turn transmits the signal to the edge cloud server 46 via the wireless gateway 52. The output signal is processed to determine the presence, and amount of viral load in the sample medium within the sample chamber 32. In particular, the edge cloud server 46, in this particular aspect of its functionality, acts as a signal processing system that estimates the viral load in the sample medium by correlating viral load in the sample medium with the frequency response of the homodyne frequency detection circuit, as measured by the differential frequency detector 42. More specifically, the frequency response of the of the homodyne frequency detection circuit is correlated with a predetermined relationship between the frequency response and the viral load (step 112 in FIG. 2A). The predetermined relationship is generated by an initial calibration process in which the frequency response is evaluated in the presence of varying amounts of virus particles in the sample medium within the sample chamber 32.

[0120] The presence and magnitude of the viral load in the airspace from with the sampled virus particles were obtained can be estimated based on the viral load detected in the sample medium based, for example, on the sampling time during which the ambient was drawn into the particle collector 24 by the fan 22; the efficiency of the particle collector 24 at removing the particles of interest from the ambient air; the volume of air drawn through the particle collector 24 during the sampling period; etc. (step 114).

[0121] The calculation of the viral load in the sample medium, and the determination of the presence and magnitude of the viral load in the sampled airspace, can be performed by the edge- cloud server 46. Alternatively, the calculation of the viral load in the sample medium, and the determination of the presence and magnitude of the viral load in the sampled airspace can be performed by other types of computing devices including, without limitation, the controller 23 itself.

[0122] As noted above, alternative embodiments of the system 10 can be configured without the reference chamber 30, the second conductivity probe 38, the second frequency generator 41, and the differential frequency detector 42; and such embodiments can forgo the use of a homodyne or heterodyne frequency detection technique to determine a frequency -response differential between conductivity probes immersed in reference and sample media. In such embodiments, the viral load in the sample medium can be estimated solely from the temporal changes in the conductivity of the sample medium due to the presence of the virus particles. [0123] The results of the air-sample analysis, i.e., viral load in the sampled airspace, can be subjected to an error-elimination process, discussed below (step 116 in FIG. 2 A). Upon data acquisition from the sensors of the system 10, an edge-computation-based validation algorithm can be run to eliminate errors and verify the results of the air-sample analysis. If the obtained result is true of its nature, the result and corresponding monitoring statistics can be published locally, and on the edge-cloud server 46. In particular, if the results of the air-sample analysis are deemed valid, the results and other environmental data can be transmitted to, and displayed and/or stored on one or more display or storage devices (step 118). For example, the system 10 can include a visual display 51 communicatively coupled to the controller 23 by a wired or wireless means. The viral load determined by the system 10 can be displayed on the display 51. A safe social distance, calculated by the edge-cloud server 46 based on the viral load and other environmental factors, also can be displayed. A technique for calculating the safe social distance is described below. [0124] Environmental data such as the ambient CO2 level, PM concentration, air temperature, and relative humidity also can be displayed on the display 51. Other information, such as a plot of the airborne viral load over time, also can be displayed. If the validated viral load is above a safe level, a warning message, such as “High Viral Load Detected. Please Use Proper Safety Precautions and Air Purification” also can be displayed.

[0125] The wireless gateway 52 facilitates communication between the controller 23, the edge- cloud server 46, and other devices on which the air-sampling results, environmental data, and warnings can be displayed, processed, and/or stored. For example, the above noted information displayed on the display 51 also can be displayed on the smart phone 54 or the desktop computer 56. Also, data can be further processed and/or stored on a local server or a cloud server (not shown). Communication between the wireless gateway 52 and the above-noted devices can be facilitated by any suitable means, such as the internet, a cellular network, Wi-Fi, a local area network, a wide area network, BLUETOOTH, etc.

[0126] The system 10 can be further configured so that, upon the detection and validation of a high viral load, the system 10 immediately generates warnings and notifications cautioning recipients to take adequate precautions, such as leaving the area, to reduce the potential for viral exposure and possible infection (step 120 of FIG. 2A). For example, the system 10 can be configured to send such warnings and notifications to pre-designated recipients by way of e-mail or SMS (text) messaging. In one possible application, and without limitation, the pre-designated recipients can include the normal occupants of a particular floor of an office building on which the system 10 is used to monitor air quality.

[0127] The system 10 also can be configured so that, upon the detection and validation of a high viral load, the system 10 generates a command that activates an air filtration, disinfection, or ventilation system (not shown) that services the airspace in which the viral load have been detected (step 122).

[0128] The system 10 further can include a visual alerting device in the form of one or more LED displays 58, shown in FIG. 1. The LED displays 58 are communicatively coupled to the edge-cloud server 46, and can be placed in locations where they can be seen easily by occupants within the space being monitored by the system 10. Upon receiving an input from the edge- cloud server 46 that a high viral load or other alarming condition exists, the LED displays 58 illuminate, thereby providing a visual indication to those in the vicinity of the LED displays 58 that the viral load in the local space is at, or is approaching an unsafe level (step 124).

[0129] The system 10 further can include an audible alerting device in the form of one or more buzzers 60, depicted in FIG. 1. The buzzers 60 are communicatively coupled to the edge-cloud server 46, and can be placed in locations where they can be heard easily by occupants within the space being monitored by the system 10. Upon receiving an input from the edge-cloud server 46 that a high viral load or other alarming condition exists, the buzzers 60 emit an audible sound such as a pulsing buzzing noise, thereby providing an audible indication to those in the vicinity of the buzzers 60 that the viral load in the local space is at, or is approaching an unsafe level (step 126). The audible alert provided by the buzzers 60 can be particularly helpful when the user of the system 10 is not attentive to the visual alert provided by the LED displays 58.

[0130] The above warning and notification processes can be initiated by other computing devices, such as the controller 23, in alternative embodiments.

[0131] An embodiment of the system 10 was tested with different polar aprotic solvents with distilled water, double deionized water, and a solution of pure water with slightly basic salts.

The frequencies of the respective AC currents passing through the probes immersed in the sample and reference media were recorded with every viral dosage. The virus selected for the testing was a live attenuated MMR (measles, mumps and rubella) vaccine, at a concentration of 140 viral particles per 10 pL. As can be seen in Fig. 6A, the frequency of the output of the sample probe increased linearly as the viral load was increased. As can be seen in Fig. 6B, the difference between the output frequencies of the sample probe and the reference probe likewise increased linearly as the viral load was increased. The testing also was conducted using polio and rotavirus live attenuated vaccines; and similar frequency responses were found using these viruses. Depending on coronal spike structure of the different virus particles, and their timing in the air and the manner in which the particles interface with water droplets, each type of virus particle will generate different level of Zeta potential and Debye radius. Therefore, the system 10 relies on an advanced adaptive signal processing technique of comparing the response of the sample probe with a time series of baseline data to predict whether there is a burst of viral activities in the monitored airspace.

[0132] Referring to FIG. 7, the error-elimination process can be performed using a sensor- based validation approach that employs a validation, or error elimination algorithm stored on, and executed by the edge-cloud server 46. The validation algorithm can be stored on and executed by a different computing device, such as the controller 23, in alternative embodiments. The error-elimination process is based on inputs such as the carbon dioxide (CO2) level in the space from which the sample was obtained; the particulate matter (PM) concentration and distribution within the space; and the presence or absence of people in the space.

[0133] The carbon dioxide concentration and the particulate matter concentration can be obtained from a respective carbon dioxide sensor 62 and particulate matter sensor 64, depicted in FIG. 1. The presence and/or number of persons in the space can be evaluated based on inputs from one or more proximity sensors or motion detectors 86. The carbon dioxide sensor 62, particulate matter sensor 64, and proximity sensors or motion detectors 86 can be communicatively coupled to the edge cloud server 46 by way of the wireless gateway 52, as illustrated in FIG. 1.

[0134] Referring again to Fig. 7, the CO2 level, PM concentration, and the presence or absence of people are factors that can indicate the likelihood that an airborne virus is present in a particular space. For example, a relatively low level of carbon dioxide, e.g., about 400 ppm or less, and/or a relatively low particulate level, e.g., about ten ug/m³ (micro grams per cubic meter) or less, in the presence of one or more people in the space is an indication that the space has effective ventilation, which in turn is interpreted an indication that the likelihood of a significant viral load in the space is low. The absence of any people in the space likewise is interpreted an indication that the likelihood of a significant viral load in the space is low. Thus, if the system 10 generates an output indicating an unacceptably high viral load under such circumstances, the output is interpreted as a false positive, i.e., the result is considered invalid. The suspect result can be ignored, and if desired, the user can initiate another sampling cycle.

[0135] Conversely, a relatively high level of carbon dioxide, e.g., about 420 to about 450 ppm or greater, and/or a relatively high particulate level, e.g., about 50 ug/m³ to about 100 ug/m³ or greater, in the presence of one or more people in the space is an indication that the space has poor ventilation, which in turn is interpreted an indication that the likelihood of a significant viral load in the space is high. Thus, if the system 10 generates an output indicating an acceptably low viral load under such circumstances, the output is interpreted as a false negative, i.e., the result is considered invalid. The suspect result can be ignored, and if desired, the user can initiate another sampling cycle. [0136] Alternatively, or in addition to the above-noted sensor-based validation approach, the error-elimination process can be performed using a signal-analytics-based approach that employs an additional error-elimination, or validation algorithm depicted in FIG. 8. The validation algorithm correlates signal artifacts, such as skewness, coefficient of variation, variance, etc. with the presence or absence of a viral load in the sample medium, to help eliminate false positive or false negative indications of a viral load by the system 10. The validation algorithm depicted in FIG. 8 can be stored on, and executed by the edge-cloud server 46. The validation algorithm can be stored on and executed by a different computing device, such as the controller 23, in alternative embodiments

[0137] As can be seen in FIG. 8, the validation algorithm is developed by conducting pre processing of the output signal received from the differential frequency detector 42; followed by feature-extraction, and the use of a supervised machine learning technique to develop a two-class classification algorithm that determines whether a viral load is or is not present based on one or more of the signal artifacts. FIG. 9 includes a non-exclusive listing of various statistical parameters, i.e., different signal artifacts, can extracted from the output signal and correlated with the viral load, to help maximize the accuracy of the validation process under different settings and conditions. FIG. 9 also includes a non-exclusive listing of various machine-learning techniques that can be used to develop the two-class classification algorithm.

[0138] Referring again to FIG. 8, the validation algorithm also incorporates a regression analysis technique to generate an algorithm for estimating the magnitude of the viral load, if one is present, based on the statistical parameters extracted from the output signal. As also can be seen in FIG. 8, once the magnitude of the viral load has been estimated, the validation algorithm can determine whether the magnitude exceeds a threshold indicating a high or otherwise significant viral load.

[0139] As an example, the technology disclosed herein was used with different engineered media to detect pseudovirions for SARS Cov-2 with s-spike protein. A validation process as depicted in FIG. 8 was performed on the results, and the results of the validation process are shown in FIG. 10.

[0140] After the viral load has been verified by one or both of the above validation techniques, the frequency-based conductivity signal, i.e., the output signal received from the differential frequency detector 42, and the estimated viral load can be communicated to one of more of the various display and alert devices discussed above and depicted in FIGS. 1 and 11, by way of the wireless gateway 52.

[0141] The edge-cloud server 46 can be configured to determine the minimum social distance, based on the environmental conditions in the space being monitored. In particular, the edge- cloud server 46 can be programmed with algorithms that, when executed by the edge-cloud server 46, calculate the minimal social distance at a given time based on the measured temperature and humidity of the ambient air; and the concentration and size distribution of particles in the ambient air.

[0142] It is believed that the size of the droplet nuclei resulting from sneezing, coughing, and talking is a function of the process by which the droplets are generated, and the environmental conditions. For example, sneezing can generate around 40,000 droplets in the aboutt 0.5 micron to about 12 micron range, which most likely are aerosolized. Also, studies have shown that talking for five minutes can generate the same number of droplet nuclei as a cough, i.e., about 3,000 droplet nuclei. The actual size distribution of the droplets is dependent on parameters such as the exhaled air velocity, the viscosity of the fluid, and the flow path.

[0143] Human-to-human transmission of pathogens such as the COVID-19 virus takes place via droplets, or aerosol transportation, from one individual to another. After being exhaled by an infected person, respiratory droplets with various sizes travel and simultaneously evaporate in the ambient air. The droplets begin to exchange heat and mass with the ambient air while moving under the influence of various forces such as gravity, buoyancy, and air drag. It is believed that the respiratory droplets evolve into two categories, large and small-sized droplets, depending on their initial diameter. Large-sized droplets can reach limited distance, whereas small-sized droplets dry to form a cloud of aerosol particles that can remain suspended in the air for a significant amount of time.

[0144] The time of flight and distance traveled by exhaled particles depend upon the transport characteristics of the ambient air, i.e., the viscosity, temperature, specific heat capacity, and thermal conductivity of the ambient air. The transport characteristics vary with the ambient temperature and relative humidity, and hence can change the minimum social distance required to minimize the potential for person-to-person transmission of pathogens carried by exhaled particles. The following set of equations can be used to estimate the distance an exhaled particle will travel, using the temperature and relative humidity of the air through which the particle will travel, and the concentration of particles in the air:

[0145] Because the minimum social distance is related to the distance an exhaled particle will travel, the above equation set can be used to estimate the minimum social distance based on the ambient temperature and relative humidity, and the particle concentration in the ambient air. [0146] The parameters used in the above equation set are air transport characteristics at different temperatures and different relative humidity (RH) values, where: r_p = Radius of the droplet

T_p = Temperature of the droplet

V_p = Velocity of the droplet

X_p = Distance traveled by the droplet

[0147] The edge-cloud server 46 is configured to perform a Runge Kutta Fourth Order Method to solve the above differential equations for the distance traveled by the droplet under the specific conditions existing at a particular time. The distance traveled by the droplet represents the minimum separation distance for that particular point in time.

[0148] FIG. 13 is a diagrammatic representation depicting an alternative embodiment of the system 10. The alternative embodiment comprises a tube, such as the type of tube used in breathalyzer machines, in fluid communication with a sample chamber holding a solvent. A user can breathe into the tube. If the user is infected with a virus, such as the COVID-19 virus, this action will result in the introduction of virus particles into the sample chamber, and the deposition and suspension of the virus particles in the solvent. The alternative embodiment can detect the presence of the virus particles in the manner described above in relation to the system

10

Claims

We claim:

1. A system for detecting the presence of a viral load in an airspace, comprising: a conductivity probe; a frequency generator communicatively coupled to the conductivity probe and configured to, during operation, apply an alternating voltage to the conductivity probe while the conductivity probe is immersed at least in part in a medium comprising a solvent, and particles sampled from the airspace and suspended in the solvent, the first alternating voltage causing an alternating current to flow between the conductivity probe and the frequency generator; and a computing device communicatively coupled to the frequency generator and configured to, during operation, determine a viral load in the medium based on a frequency response of the conductivity probe to the alternating voltage applied thereto.

2. The system of claim 1, wherein system is further configured to, during operation, determine the viral load in the medium based on a correlation between the frequency response of the conductivity probe to the alternating voltage applied thereto, and the viral load.

3. The system of claim 1, further comprising the medium, wherein the solvent is one of a liquid and a gel-like solid or semi-solid.

4. The system of claim 3, wherein the solvent is selected from a class of materials capable of acting as a base of a colloidal suspension in which the particles are suspended after being separated from the airspace, and further capable of effecting a transfer of charge between particles and the solvent.

5. The system of claim 3, wherein the solvent is one of deionized water; distilled water; isopropyl alcohol; ultra-low molal tris-salt medium; a mild basic salt medium; and disodium laureth sulfosuccinate medium.

6. The system of claim 3, wherein the solvent has conductivity of about one microsiemens or less.

7. The system of claim 1, wherein the computing device is further configured to, during operation, extract one or more signal artifacts from a signal representing the frequency response of the conductivity probe to the alternating voltage applied thereto; and to correlate the viral load in the medium with the one or more signal artifacts to thereby reduce or eliminate false positives and false negatives in the viral load determined by the computing device.

8. The system of claim 7, wherein the signal representing the frequency response of the conductivity probe to the alternating voltage applied thereto is a temporal signal.

9. The system of claim 7, wherein the signal representing the frequency response of the conductivity probe to the alternating voltage applied thereto is a frequency-based signal representing the conductivity of the medium.

10. The system of claim 7, wherein the computing device is further configured to correlate the one or more signal artifacts with the viral load in the medium using a rule engine developed from a machine learning technique.

11. The system of claim 1, wherein the computing device is further configured to reduce or eliminate false positives and false negatives in the viral load determined by the computing device using at least one of a particulate matter level, a carbon dioxide level, and the presence or absence of people in the airspace.

12. The system of claim 1, wherein: the conductivity probe is a first conductivity probe; the frequency generator is a first frequency generator; the medium is a first medium; the system further comprises: a second conductivity probe; a second frequency generator communicatively coupled to the second conductivity probe and configured to, during operation, apply a second alternating voltage to the second conductivity probe while the second conductivity probe is immersed at least in part in a second medium comprising the solvent, the second alternating voltage causing a second alternating current to flow between the second conductivity probe and the second frequency generator; and a differential frequency detector communicatively coupled to the first and second frequency generators and the computing device and configured to, during operation, determine a frequency differential between the frequencies of the first and second alternating currents; and the computing device is further configured to, during operation, determine the viral load in the first medium based on the frequency differential.

13. The system of claim 12, wherein the second medium is free of virus particles.

14. The system of claim 12, wherein the computing device is further configured to determine a pattern difference between signals representing the frequency responses of the first and second conductivity probes to the respective first and second alternating voltages applied thereto; and the patterns are artifacts of the signals.

15. The system of claim 12, wherein the computing device is further configured to, during operation, determine the viral load in the first medium using one of a homodyne and a heterodyne detection technique.

16. The system of claim 1, wherein the computing device is further configured to estimate the viral load in the airspace based on the viral load in the first medium.

17. The system of claim 16, wherein the computing device is further configured to generate and send a notification when the viral load in the airspace is determined to be greater than a predetermined value.

18. The system of claim 16, further comprising a visual altering device communicatively coupled to the computing device, wherein: the computing device is further configured to generate an output when the viral load in the airspace is determined to be greater than a predetermined value; and the visual alerting device is configured to generate a visual alert in response to the output of the computing device.

18. The system of claim 15, further comprising an audible altering device communicatively coupled to the computing device, wherein: the computing device is further configured to generate an output when the viral load in the airspace is determined to be greater than a predetermined value; and the audible alerting device is configured to generate an audible alert in response to the output of the computing device.

20. The system of claim 1, wherein the computing device is an edge-cloud server.

21. The system of claim 1, further comprising a particle collector in fluid communication with the airspace and configured to, during operation, separate the particles from a sample of the airspace.

22. The system of claim 21, wherein the particle collector comprises a coarse filter configured to remove from the sample of the airspace particles having a size greater than a predetermined value.

23. The system of claim 22, wherein the coarse filter is configured to remove from the sample of the airspace particles having an aerodynamic diameter greater than about ten microns.

24. The system of claim 21, wherein the particle collector further comprises a particle separator configured to remove from the sample of the airspace the particles sampled from the airspace.

25. The system of claim 21, further comprising a fan in fluid communication with the particle collector and configured to, during operation, direct the sample from the airspace and to the particle collector.

26. The system of claim 1, further comprising a tube in fluid communication with an interior of a chamber holding the solvent, wherein the tube is configured so that a person can breathe into the tube and thereby introduce airborne virus particles into the solvent via the tube.

27. A process for detecting the presence of a viral load in an airspace, comprising: providing a solvent; obtaining an air sample from the airspace; separating particles from the air sample so that the particles become suspended in the solvent to form a medium; immersing at least a portion of a conductivity probe in the medium; applying an alternating voltage to the conductivity probe; and determining a viral load in the medium based on a frequency response of the conductivity probe to the alternating voltage applied thereto.

28. The process of claim 27, wherein determining a viral load in the medium based on a frequency response of the conductivity probe to the alternating voltage applied thereto comprises determining the viral load in the medium based on a correlation between the frequency response of the conductivity probe to the alternating voltage applied thereto, and the viral load.

29. The process of claim 27, wherein providing a solvent comprises selecting the solvent from a class of materials capable of acting as a base of a colloidal suspension in which the particles are suspended after being separated from the airspace, and further capable of effecting a transfer of charge between the particles and the solvent.

30. The process of claim 27, further comprising reducing or eliminating false positives and false negatives in the viral load determination by extracting one or more signal artifacts from a signal representing the frequency response of the conductivity probe to the alternating voltage applied thereto; and correlating the viral load in the medium with the one or more signal artifacts.

31. The process of claim 30, wherein correlating the viral load in the medium with the one or more signal artifacts comprises correlating the viral load in the medium with the one or more signal artifacts using a rule engine developed from a machine learning technique.

32. The process of claim 27, further comprising reducing or eliminating false positives and false negatives in the viral load determination using at least one of a particulate matter level, a carbon dioxide level, and the presence or absence of people in the airspace.

33. The process of claim 27, wherein: the conductivity probe is a first conductivity probe; the medium is a first medium; the alternating voltage is a first alternating voltage; the process further comprises: providing a second conductivity probe; applying a second alternating voltage to the second conductivity probe while the second conductivity probe is immersed at least in part in a second medium comprising the solvent; determining a differential between the frequency response of the first conductivity probe to the alternating voltage applied thereto and a frequency response of the second conductivity probe to the alternating voltage applied thereto; and determining the viral load in the medium based on the frequency differential.

34. The process of claim 33, wherein the second medium is free of virus particles.

35. The process of claim 33, wherein determining the viral load in the medium based on the frequency differential comprises determining the viral load in the first medium based on one of a homodyne and a heterodyne frequency detection technique.

36. The process of claim 33, wherein determining a viral load in the medium based on the frequency differential comprises determining the viral load in the medium based on a predetermined relationship between the viral load in the first volume and the frequency differential.

37. The process of claim 33, further comprising maintaining the first and second media at substantially the same temperature.

38. The process of claim 27, further comprising estimating the viral load in the airspace based on the viral load in the medium.

39. The process of claim 38, further comprising generating and sending a notification when the viral load in the airspace is determined to be greater than a predetermined value.

40. The process of claim 27, wherein separating particles from the air sample so that the particles become suspended in the solvent to form a medium comprises separating particles having an aerodynamic diameter of about ten microns or less from the air sample.

41. The process of claim 27, wherein determining a viral load in the first volume based on a frequency response of the conductivity probe to the alternating voltage applied thereto comprises determining a viral load in the first volume based on the frequency response of the conductivity probe to the alternating voltage applied thereto using an edge-cloud server.

42. The process of claim 27, further comprising: measuring a temperature and a relative humidity of the airspace; determining a particle concentration in the airspace; and calculating a minimum separation distance needed to reduce a potential for human-to- human transmission of airborne pathogens, based on an estimate of distance the particles will travel upon being exhaled as determined using the temperature and relative humidity of the airspace, and the particle concentration in the airspace.

43. The process of claim 27, further comprising: providing a tube in fluid communication with an interior of a chamber holding the solvent; and breathing into the tube to introduce airborne virus particles into the solvent via the tube.